Identifying and definitional attributes | |
Metadata item type: | Indicator Set |
---|---|
Indicator set type: | Other |
METEOR identifier: | 745144 |
Registration status: | Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 |
Description: | The Australian Commission on Safety and Quality in Health Care has produced these indicators to support health service organisations to monitor how well they are implementing the care recommended in the Acute Anaphylaxis Clinical Care Standard. The indicators included in this specification are a tool to support local clinical quality improvement and may be used to support other quality assurance and peer review activities. The goal of the Acute Anaphylaxis Clinical Care Standard is to improve the recognition of anaphylaxis, and the provision of appropriate treatment and follow-up care. The Acute Anaphylaxis Clinical Care Standard relates to the care provided to adults, children and infants when they are experiencing anaphylaxis – from initial presentation to a healthcare setting or first clinical contact in the community, through to discharge and planning for follow-up care. It also applies to many patients who experience anaphylaxis while in a healthcare facility. The Acute Anaphylaxis Clinical Care Standard does not include:
This standard applies to care provided in the following care settings:
A clinical care standard contains a small number of quality statements that describe the clinical care expected for a specific clinical condition or procedure. Indicators are included for some quality statements to help health service organisations monitor how well they are implementing the care recommended in the clinical care standard. The quality statements that are included in the Acute Anaphylaxis Clinical Care Standard are as follows:
|
Relational attributes | |
Indicators linked to this Indicator set: | Acute Anaphylaxis Clinical Care Standard: 01-Evidence of a locally approved anaphylaxis pathway Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 Acute Anaphylaxis Clinical Care Standard: 02-Proportion of patients with anaphylaxis treated with intramuscular adrenaline Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 Acute Anaphylaxis Clinical Care Standard: 04-Evidence of a locally approved policy to ensure patients maintain access to their personal adrenaline injectors. Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 Acute Anaphylaxis Clinical Care Standard: 06a-Evidence of local arrangements that ensure patients treated for anaphylaxis receive tailored discharge planning prior to separation from hospital. Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 |
---|---|
Collection and usage attributes | |
National reporting arrangement: | Clinicians and health service organisations may choose to prioritise some of the suggested indicators based on the focus of quality improvement activities at the health service. No benchmarks are set for the indicators. |
Comments: | Monitoring the implementation of the Acute Anaphylaxis Clinical Care Standard will assist in meeting some of the requirements of the National Safety and Quality Health Service Standards (ACSQHC 2017). |
Source and reference attributes | |
Submitting organisation: | Australian Commission on Safety and Quality in Health Care |
Reference documents: | Australian Commission on Safety and Quality in Health Care 2017. National Safety and Quality Health Service Standards. 2nd ed. Australian Commission on Safety and Quality in Health Care, Sydney. Australian Commission on Safety and Quality in Health Care 2021. Acute Anaphylaxis Clinical Care Standard. Australian Commission on Safety and Quality in Health Care, Sydney. |